Most Read Articles
Tristan Manalac, 12 Jun 2019
Exposure to air pollution appears to raise the odds of experiencing psychosis episodes during adolescence, according to a recent study.
12 Jun 2019
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 6 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

5 days ago
Elevated serum urate concentrations may be protective against dementia, regardless of subtype, reports a recent study.

Product Highlight - Bisolvon

29 Mar 2019
  • Active Ingredient: Bromhexine hydrochloride 8 mg/5 mL (high strength).
  • Indications: Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
  • Dosage & Administration: Adults and children over 12 years: 5 mL (1 tsp) 3 times daily. Children 6-12 years: 2.5 mL (1/2 tsp) 3 times daily.
  • General: At commencement of treatment, it may be necessary to increase the total daily dose up to 48 mg in adults.
    The syrup is sugar-free and alcohol-free therefore suitable for diabetics and small children.
    Patients being treated with Bisolvon should be notified of an expected increase in the flow of secretions.
    In acute respiratory indications, medical device should be sought if symptoms do not improve or worsen during course of therapy.
  • Presentation: Syrup(Choco-Cherry) 8 mg/5 mL x 60 mL x 1’s.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 12 Jun 2019
Exposure to air pollution appears to raise the odds of experiencing psychosis episodes during adolescence, according to a recent study.
12 Jun 2019
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 6 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

5 days ago
Elevated serum urate concentrations may be protective against dementia, regardless of subtype, reports a recent study.